SHANGHAI LIDE BIOTECH CO LTD has a total of 14 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2017. It filed its patents most often in Australia, Canada and China. Its main competitors in its focus markets measurement, pharmaceuticals and agriculture are BIOAGRI CORP, TRANSPOSAGEN BIOPHARMACEUTICALS INC and JACKSON LAB.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 2 | |
#2 | Canada | 2 | |
#3 | China | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Republic of Korea | 2 | |
#6 | United States | 2 | |
#7 | Singapore | 1 | |
#8 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Pharmaceuticals | |
#3 | Agriculture | |
#4 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Animal care | |
#2 | Analysing materials | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Wen Danyi | 12 |
#2 | Zhang Feifei | 7 |
#3 | Li Rongyu | 1 |
#4 | Di Yu | 1 |
#5 | Van Loc | 1 |
#6 | Wen Danyl | 1 |
Publication | Filing date | Title |
---|---|---|
AU2019250859A1 | Method for obtaining an animal model from conditionally reprogrammed cells and use of the animal model for screening anti-tumor drugs | |
US2019154663A1 | Method and device for drug screening | |
CN108165546A | A kind of miRNA biomarker, composition and application thereof |